Upregulation of IGFBP2 expression was associated with angiogenic mimetic (VM) formation, leading to resistance to anti-VEGF therapy in glioma and had a significant immunosuppressive activity in GBM, which was negatively associated with patient survival (11). This evidence concerns the gene IGFBP2 and glioblastoma.